2026-09-01T15:55:38.000Z · 4 weeks ago Elevance update guidelines cover Freenome CRC test, says Guggenheim ELV GH
2026-08-18T20:55:15.000Z · 6 weeks ago Freenome files to sell 75.19M shares of common stock for holders
2026-08-17T09:26:03.000Z · 6 weeks ago Freenome granted Breakthrough Device Designation for SimpleScreen Lung
Aug 12, 2026, 9:00 AM EDT · 7 weeks ago FDA Grants Breakthrough Device Designation to Freenome's Blood-Based SimpleScreen™ Lung Cancer Screening Test
Jul 27, 2026, 9:15 AM EDT · 2 months ago FDA approves Freenome's blood test for colorectal cancer screening
Jul 27, 2026, 8:00 AM EDT · 2 months ago FDA Approves Freenome's SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S. ABT
Jul 20, 2026, 4:01 PM EDT · 2 months ago Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection